查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1198671

超低温冰箱市场 - 增长、趋势、COVID-19 影响和预测2023-2028

Ultra Low Temperature Freezers Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 115 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

超低温冰箱市场预计在预测期内（2022-2027 年）以 3.9% 的复合年增长率增长。

COVID-19 对市场增长的影响是巨大的，因为超低温冰箱在储存和分发需要超低温的大量 COVID-19 疫苗方面发挥了关键作用。 根据世界卫生组织的数据，2021 年 9 月，超低温冰箱将疫苗储存容量增加到 900 万支。 低温链容量的增加使 COVAX（获取 COVID-19 工具 (ACT) 加速器的疫苗支柱）能够运送辉瑞公司从美国捐赠的 250 万剂疫苗。 此外，在大流行期间增加超低温冷水机的战略发展和产品发布也推动了市场增长。 例如，2021 年 1 月，Telstar 的 Boreas 超低温冰箱设计用于在 -86度C 下储存 COVID-19 疫苗。 该冷冻柜采用真空板高度隔热，即使环境温度为+28度C，也能保持-80度C的温度。 因此，COVID-19 对市场增长产生了重大影响。

此外，由于传染病和癌症等慢性疾病的增加，新药的发现和开发正在取得进展，并刺激了对超低温冰箱（ULTF）的需求。 研发和生物样本库对超低温冰箱的需求特别高，用于存储和运输药物、□、化学品、病毒、细菌、细胞製剂和组织样本。

此外，2021年6月，Thermo Fisher Scientific将推出TSX系列超低温（ULT），用于疫苗、细胞培养物、生物製剂和试剂等材料的可持续环保。底部。 此外，2021 年 12 月，BioLife Solutions 与联合国儿童基金会签订了一项合作协议，以在非洲、中东和南美洲的发展中社区扩展对温度敏感的 COVID-19 疫苗的热稳定性。作为该计划的一部分，联合国儿童基金会已按国家/地区批准了 Sterling 的 SU780XLE 立式冷冻机和世界上第一款便携式冷冻机 UL25NEU 型号。

在这种背景下，市场有望在预测期内呈现增长。 然而，与超低温冷冻机相关的高成本和关于超低温冷冻机的严格监管问题可能会阻碍市场增长。

超低温冰箱市场趋势

直立式超低温冰箱细分市场有望占据主要市场份额

直立式超低温冰箱随时可用，打开后快速冷却，取用方便，内部隔间可单独定制。 但是，不经常使用的物品可以安全地长期存放在卧式超低温冰箱中，因此可以将卧式超低温冰箱用于特定用途。 立式超低温冷冻机（ULT冷冻机）通常用于储存药物、□、化学品、病毒、细菌、细胞製剂、组织样本等，温度范围为-40度C至-86度C。 立式 ULT 提供的这些优势有望在不久的将来加速这些冷冻机的采用。

此外，药物和疫苗研发活动的激增推动了该行业的增长。 在接下来的几年里，我们预计会看到一些药物在临床试验中的推出，这些药物需要低温条件来储存和运输原材料。 根据国际製药商协会联合会 (IFPMA) 的数据，2021 年有 2,178 项处于 III 期试验，2020 年有 3,752 项。 因此，预计在预测期内立式超低温冰箱领域的需求将增长。

因此，上述所有因素都有望增加对立式超低温冰箱的需求，从而推动该细分市场的增长。

北美将占据很大的市场份额，预计在预测期内也会如此

由于多家生物样本库、製药公司和生物技术公司的存在，预计北美将在全球超低温冰箱市场占据重要的市场份额。 据估计，该地区在全球超低温冷冻机市场中占有相当大的份额，并且这一趋势预计将在预测期内继续。

此外，由于 COVID-19 疫苗的研发活动增加，预计 COVID-19 的爆发将在预测期内推动该地区的超低温冰箱市场。 例如，BINDER CO2 冰箱可帮助科学家在研究期间保存冠状病毒样本。

此外，技术先进的超低温冰箱的高采用率和产品发布预计将推动整个地区的市场增长。 例如，2020 年 5 月，Thermo Fisher Scientific 推出了一项新服务，从其关联的 TSX 系列超低温冰箱收集和跟踪关键性能数据，以确保样品和产品的安全。 Thermo Scientific 的智能连接系统功能允许您记录 37 个警报和 26 个运行指标，以一起彻底验证您的 TSX 系列超低温冰箱。

因此，上述所有因素预计将增加对超低温冰箱的需求，并在预测期内推动市场增长。

超低温冷冻机市场竞争者分析

所研究的市场竞争适中，有几家公司在该市场开展业务。 市场上的主要参与者包括 Thermo Fisher Scientific, Inc、PHC Holdings Corporation、Haier Biomedical、Arctiko A/S、Helmer Scientific、Eppendorf AG、Abzil Telstar S.L、Labcold Ltd、Bionics Scientific Technologies (P) Ltd 和 Global Cooling，公司

其他福利。

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第一章介绍

  • 研究假设和市场定义
  • 调查范围

第二章研究方法论

第 3 章执行摘要

第四章市场动态

  • 市场概览
  • 市场驱动力
    • 在生物样本库、药物发现和生命科学研究领域的应用扩展
    • 超低温冰箱的技术进步
  • 市场製约因素
    • 与超低温冰箱相关的高成本
    • 关于超低温冰箱的严格监管问题
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（基于价值的市场规模：100 万美元）

  • 按产品类型
    • 立式超低温冰箱
    • 卧式超低温冰箱
  • 最终用户
    • 生物样本库
    • 製药公司、生物技术公司
    • 学术和研究机构
    • 其他
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲地区
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章竞争格局

  • 公司简介
    • Thermo Fisher Scientific, Inc
    • PHC Holdings Corporation
    • Haier Biomedical
    • Arctiko A/S
    • Helmer Scientific
    • Eppendorf AG
    • Abzil Telstar S.L
    • Labcold Ltd
    • Bionics Scientific Technologies（P）Ltd
    • Global Cooling, Inc

第7章 市场机会今后动向

简介目录
Product Code: 67649

The Ultra-Low Temperature Freezers Market is expected to witness a CAGR of 3.9% during the forecast period (2022-2027).

The impact of COVID-19 on the market's growth was substantial as ultra-low temperature freezers played a crucial role in the storage and distribution of large amounts of COVID-19 vaccinations that required ultra-cold conditions. According to the World Health Organization data, in September 2021, vaccine storage capacity increased to nine million due to ultra-low temperature freezers. This increased ultra-cold chain capacity allowed COVAX, the vaccine pillar of the Access to COVID-19 Tools (ACT) Accelerator, to ship 2.5 million Pfizer-donated doses from the United States. Moreover, growing strategic developments and product launches with respect to ultra-low temperature freezers amid the pandemic have boosted the market's growth. For instance, in January 2021, Telstar's Boreas ultra-low-temperature freezers were designed to store COVID-19 vaccinations at -86°C. The freezers have vacuum panels for high degrees of insulation, allowing them to maintain a temperature of -80°C with ambient temperatures as high as +28°C. Thus, COVID-19 has had a significant impact on the growth of the market.

Moreover, rising infectious diseases, cancer, and other chronic diseases have led to new drug discoveries and development, stimulating demand for ultra-low temperature freezers (ULTF). Demand for ultra-low temperature freezers is particularly high in research and development and in biobanks for storing and transporting drugs, enzymes, chemicals, viruses, bacteria, cell preparations, and tissue samples.

Additionally, in June 2021, Thermo Fisher Scientific launched the TSX Series Ultra-Low Temperature (ULT) to deliver environmentally sustainable protection of materials such as vaccines, cell culture media, biologics, and reagents. Furthermore, in December 2021, BioLife Solutions, Inc. signed a partnership agreement with UNICEF to extend the thermal stability of temperature-sensitive COVID-19 vaccines in developing communities in Africa, the Middle East, and South America. As part of this program, UNICEF has approved Stirling's upright SU780XLE freezers and first-of-its-kind, portable UL25NEU freezer models for country-specific selection.

Thus, owing to the abovementioned factors, the market is expected to show growth over the forecast period. However, high costs associated with ultra-low temperature freezers and stringent regulatory issues regarding ultra-low temperature freezers may hinder the growth of the market.

Ultra Low Temperature Freezers Market Trends

Upright Ultra-Low Temperature Freezers Segment is Expected to Hold a Major Market Share

The upright ULT freezer enables quick cooling after opening, simple access, and individually customizable inner compartments for regular usage. However, less used items can be stored in a chest ULT freezer safely for an extended period of time that allows the usage of the chest ULT for specific purposes. Upright ultra-low temperature freezers (ULT freezers) typically have a temperature range of -40°C to -86°C and are used to store drugs, enzymes, chemicals, viruses, bacteria, cell preparations, and tissue samples. Such advantages offered by upright ULTs are anticipated to boost the adoption of these freezers in the near future.

Moreover, the segment's growth is driven by a surge in research and development activities for pharmaceutical drugs and vaccines. Several medicines under clinical trial are expected to be launched over the coming years that may require ultra-cold conditions for storage and transportation of raw materials. According to the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), in 2021, 2,178 are in Phase III trials, and 3,752 are in Phase II trials in 2020. Thus, the demand for the upright ultra-low temperature freezer segment is expected to grow over the forecast period.

Thus, all the above factors are expected to increase demand for upright ultra-low temperature freezers, thereby boosting the segment's growth.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same Over the Forecast Period

North America is expected to hold a significant market share in the global ultra-low temperature freezers market due to the presence of several biobanks, pharmaceutical and biotechnology companies within the region. The region is estimated to hold a substantial share of the global ultra-low temperature freezers market, and the trend is projected to continue during the forecast period.

Moreover, the COVID-19 outbreak is anticipated to drive the ultra-low temperature freezer market over the forecast period in the region owing to an increase in research and development activities for COVID-19 vaccines. For example, the BINDER CO2 freezer is helping scientists retain coronavirus samples during research.

Furthermore, the high adoption of technologically advanced ultra-low temperature freezers and product launches is expected to propel the growth of the overall regional market. For instance, in May 2020, Thermo Fisher Scientific launched a new service that collects and tracks crucial performance data from the linked TSX Series ULT freezers to ensure the safety of samples and products. Thermo Scientific's intelligent connected systems function keeps track of 37 types of alarms and 26 operating metrics, enabling the user to examine the linked TSX Series ULT freezers thoroughly.

Thus, all the factors mentioned above are expected to increase demand for ultra-low temperature freezers and boost market growth over the forecast period.

Ultra Low Temperature Freezers Market Competitor Analysis

The market studied is moderately competitive, and several companies are operating in this market. Some of the major players operating in the market include Thermo Fisher Scientific, Inc., PHC Holdings Corporation, Haier Biomedical, Arctiko A/S, Helmer Scientific, Eppendorf AG, Abzil Telstar S.L, Labcold Ltd., Bionics Scientific Technologies (P) Ltd., and Global Cooling, Inc., among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Applications in Bio-Banks, Drug Discovery and life-Sciences Research
    • 4.2.2 Technological Advancement in Ultra-Low Temperature Freezers
  • 4.3 Market Restraints
    • 4.3.1 High Costs Associated with Ultra-Low Temperature Freezers
    • 4.3.2 Stringent Regulatory Issues Regarding Ultra-Low Temperature Freezers
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product Type
    • 5.1.1 Upright ULT freezers
    • 5.1.2 Chest ULT freezers
  • 5.2 By End User
    • 5.2.1 Bio-Banks
    • 5.2.2 Pharmaceutical and Biotechnology Companies
    • 5.2.3 Academic and Research Laboratories
    • 5.2.4 Others
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Thermo Fisher Scientific, Inc
    • 6.1.2 PHC Holdings Corporation
    • 6.1.3 Haier Biomedical
    • 6.1.4 Arctiko A/S
    • 6.1.5 Helmer Scientific
    • 6.1.6 Eppendorf AG
    • 6.1.7 Abzil Telstar S.L
    • 6.1.8 Labcold Ltd
    • 6.1.9 Bionics Scientific Technologies (P) Ltd
    • 6.1.10 Global Cooling, Inc

7 MARKET OPPORTUNITIES AND FUTURE TRENDS